Status:
COMPLETED
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
Lead Sponsor:
National Yang Ming Chiao Tung University
Collaborating Sponsors:
Taipei Veterans General Hospital, Taiwan
Conditions:
Randomized Controlled Trial
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Introduction Low levels of physical activity and central obesity contribute to metabolic syndrome in patients with schizophrenia. Aim This study was to examine the effectiveness of Baduanjin program ...
Detailed Description
This study was conducted in a large psychiatric center that has 10 residential rehabilitation units. Residents were allowed to walk for 20 min during 6-7 pm every day, and each unit could accommodate ...
Eligibility Criteria
Inclusion
- People were diagnosed with schizophrenia at the age of 20-65 years.
- People had taken regular antipsychotic medication for more than 10 weeks
- People lacked regular exercise in the past 3 months.
- People consented to receive blood collection and complete a questionnaire.
- People satisfied the modified Adult Treatment Panel III criteria for Asians i.e., three abnormal results for metabolic syndrome or two abnormal results with BMI \> 25)
Exclusion
- People with organic mental disorders, alcohol dependence, and substance abuse.
- people who are not willing to sign the consent.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04027634
Start Date
September 1 2014
End Date
December 1 2014
Last Update
July 22 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.